Computed tomography correlates with cardiopulmonary hemodynamics in pulmonary hypertension in adults with sickle cell disease

Pulmonary Circulation

Volumn 4, Issue 2, 2014, Pages 319-329

  Linguraru, Marius George ^a,b,c   Pura, John A ^b,d   Gladwin, Mark T ^e   Koroulakis, Antony I ^a,c   Minniti, Caterina ^f   Machado, Roberto F ^g   Kato, Gregory J ^e   Wood, Bradford J ^b  

^a CHILDREN S NATIONAL HOSPITAL   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Arterial size; Cardiopulmonary hemodynamics; CT angiography; Pulmonary hypertension; Quantitative imaging; Sickle cell disease

Indexed keywords

EID: 85026337485     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.1086/675997     Document Type: Article

References (34)

1. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004;350(9):886-895.
2. Linguraru MG, Pura JA, Van Uitert RL, Mukherjee N, Summers RM, Minniti C, Gladwin MT, Kato G, Machado RF, Wood BJ. Segmentation and quantification of pulmonary artery for noninvasive CT assessment of sickle cell secondary pulmonary hypertension. Med Phys 2010;37(4):1522-1532.
3. Lin EE, Rodgers GP, Gladwin MT. Hemolytic anemiaassociated pulmonary hypertension in sickle cell disease. Curr Hematol Rep 2005;4(2):117-125.
4. Machado RF, Gladwin MT. Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective. Chest 2010;137(6 suppl.):30S-38S.
5. Mehari A, Alam S, Tian X, Cuttica MJ, Barnett CF, Miles G, Xu D, et al. Hemodynamic predictors of mortality in adults with sickle cell disease. Am J Respir Crit Care Med 2013;187(8):840-847.
6. Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G, Habibi A, et al. A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med 2011;365(1):44-53.
7. Mehari A, Gladwin MT, Tian X, Machado RF, Kato GJ. Mortality in adults with sickle cell disease and pulmonary hypertension. JAMA 2012;307(12):1254-1256.
8. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54(1 suppl.):S43-S54.
9. Sachdev V, Machado RF, Shizukuda Y, Rao YN, Sidenko S, Ernst I, St Peter M, et al. Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J Am Coll Cardiol 2007;49(4):472-479.
10. Knight-Perry JE, de las Fuentes L, Waggoner AD, Hoffmann RG, Blinder MA, Dávila-Román VG, Field JJ. Abnormalities in cardiac structure and function in adults with sickle cell disease are not associated with pulmonary hypertension. J Am Soc Echocardiogr 2011;24(11):1285-1290.
11. Anthi A, Machado RF, Jison ML, Taveira-DaSilva AM, Rubin LJ, Hunter L, Hunter CJ, et al. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am J Respir Crit Care Med 2007;175(12):1272-1279.
12. Machado RF, Anthi A, Steinberg MH, Bonds D, Sachdev V, Kato GJ, Taveira-DaSilva AM, et al. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA 2006;296(3):310-318.
13. Fonseca GHH, Souza R, Salemi VMC, Jardim CVP, Gualandro SFM. Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease. Eur Respir J 2012;39(1):112-118.
14. Gladwin MT. Prevalence, risk factors and mortality of pulmonary hypertension defined by right heart catheterization in patients with sickle cell disease. Expert Rev Hematol 2011; 4(6):593-596.
15. Avouac J, Huscher D, Furst DE, Distler O, Allanore Y. Expert consensus for performing right heart catheterization in suspicion of pulmonary arterial hypertension associated with systemic sclerosis: a Delphi consensus study with cluster analysis from the EPOSS Group. Ann Rheum Dis 2012;71(suppl. 3):132.
16. Grubstein A, Benjaminov O, Dayan DB, Shitrit D, Cohen M, Kramer MR. Computed tomography angiography and high resolution computed tomography signs of pulmonary hypertension: correlation with clinical and hemodynamic parameters. Isr Med Assoc J 2008;10(2):117-120.
17. Grosse C, Grosse A. CT findings in diseases associated with pulmonary hypertension: a current review. Radiographics 2010;30(7):1753-1777.
18. Froelich JJ, Koenig H, Knaak L, Krass S, Klose KJ. Relationship between pulmonary artery volumes at computed tomography and pulmonary artery pressures in patients withand without pulmonary hypertension. Eur J Radiol 2008;67(3):466-471.
19. Beiderlinden M, Kuehl H, Boes T, Peters J. Prevalence of pulmonary hypertension associated with severe acute respiratory distress syndrome: predictive value of computed tomography. Intensive Care Med 2006;32(6):852-857.
20. Kuriyama K, Gamsu G, Stern RG, Cann CE, Herfkens RJ, Brundage BH. CT-determined pulmonary artery diameters in predicting pulmonary hypertension. Investig Radiol 1984; 19(1):16-22.
21. Edwards PD, Bull RK, Coulden R. CT measurement of main pulmonary artery diameter. Br J Radiol 1998;71(850): 1018-1020.
22. McLaughlin V. Managing pulmonary arterial hypertension and optimizing treatment options: prognosis of pulmonary artery hypertension. Am J Cardiol 2013;111(8 suppl.):10C-15C.
23. Sethian JA. Level set methods and fast marching methods. Cambridge: Cambridge University Press, 1999.
24. Casselles V, Kimmel R, Sapiro G. Geodesic active contours. Int J Comput Vision 1997;22(1):61-79.
25. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;327(8476):307-310.
26. Hastie T, Tibshirani R, Friedman J. The elements of statistical learning: data mining, inference, and prediction. 2nd ed. New York: Springer, 2009.
27. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weights be known. Arch Intern Med 1916;17(6):863-871.
28. DeLong ER, DeLong DM, Clarke-Pearson, DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44(3):837-845.
29. Lackland DT. High blood pressure: a lifetime issue. Hypertension 2009;54(3):457-458.
30. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004;351(16):1655-1665.
31. Devaraj A, Wells AU, Meister MG, Corte TJ, Hansell DM. The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension. Radiology 2008;249 (3):1042-1049.
32. Alam S, Kato GJ. Sickle cell disease-associated pulmonary hypertension: the effect of anemia and high cardiac output. Pulm Hypertens 2011;2(2):45-59.
33. D’Alto M, Mahadevan VS. Pulmonary arterial hypertension associated with congenital heart disease. Eur Respir Rev 2012;21(126):328-337.
34. Karazincir S, Balcı A, Seyfeli E, Akoğlu S, Babayiğit C, Akgül F, Yalçın F, Eğilmez E. CT assessment of main pulmonary artery diameter. Diagn Interv Radiol 2008;14(2): 72-74.